Ceftacrit-TZ Injection is a broad-spectrum antibiotic combination containing Ceftazidime, a third-generation cephalosporin, and Tazobactam, a β-lactamase inhibitor. This powerful formulation is designed to combat a wide range of moderate to severe bacterial infections, including those caused by resistant organisms.
Ceftazidime works by inhibiting bacterial cell wall synthesis, leading to bacterial cell death, while tazobactam protects ceftazidime from enzymatic degradation by β-lactamase-producing bacteria. Together, they enhance antibacterial efficacy against Gram-positive, Gram-negative, and Pseudomonas aeruginosa infections.
Ceftacrit-TZ is commonly used in the treatment of lower respiratory tract infections, urinary tract infections, intra-abdominal infections, skin and soft tissue infections, septicemia, and hospital-acquired infections. The injection is supplied as a sterile lyophilized powder for intramuscular or intravenous administration, ensuring rapid action and dependable therapeutic outcomes under medical supervision.
For IM or IV use only, to be administered strictly as prescribed by a qualified healthcare professional.
Store below 25°C in a dry place. Protect from light. Do not freeze. Keep out of reach of children.
This information is for registered medical practitioner only. Anyone other than medical practitioner should consult medical practitioner before using this product.